Sources 7.31.24
ACOG-
https://www.businesswire.com/news/home/20240729327804/en/
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-medicines-regulator-rejects-eisai-biogen-alzheimers-drug-2024-07-26/
https://www.alphacognition.com/investors/news/alpha-cognitions-oral-therapy-zunveyl-receives-fda-approval-to-treat-alzheimers-disease-
https://img1.wsimg.com/blobby/go/52c4f651-6804-4f11-a210-d41e33f401de/downloads/N218549-Zunveyl-benzgalantamine-PI-CLEAN_25Jul-0001.pdf?ver=1722254587532
https://alzheimersnewstoday.com/news/fda-approves-zunveyl-alzheimers-therapy-better-tolerability/
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-169_Reminyl.cfm#:~:text=Approval%20Date%3A%202%2F28%2F2001
https://www.drugs.com/medical-answers/razadyne-galantamine-treat-alzheimer-3573460/#:~:text=The%20immediate%2Drelease%20(IR),generic%20equivalents%20are%20still%20available.
https://raymondjames.bluematrix.com/links2/html/48ca9d80-82af-4c00-b5a5-29b71d9bf93b
https://www.sec.gov/Archives/edgar/data/1655923/000121390024052607/ea0207296-02.htm#T11

Press Releases Update
VKTX-
https://ir.vikingtherapeutics.com/2024-07-24-Viking-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Provides-Corporate-Update
https://app.webinar.net/8LQbDkRP5OR
BTIG (7/24/24) and HCW (7/25/24) equity research reports available at request
ALT-
https://ir.altimmune.com/news-releases/news-release-details/altimmune-announces-publication-clinical-study-pemvidutide
https://www.journal-of-hepatology.eu/article/S0168-8278(24)02362-6/fulltext#secsectitle0055
ATNM- 
https://ir.actiniumpharma.com/press-releases/detail/483/actinium-pharmaceuticals-to-present-at-the-3rd-annual
https://ir.actiniumpharma.com/press-releases/detail/484/actinium-announces-fda-clearance-of-iomab-act-targeted
CKPT and FBIO-
https://ir.checkpointtx.com/news-events/press-releases/detail/111/u-s-food-and-drug-administration-issues-complete-response
https://ir.checkpointtx.com/news-events/press-releases/detail/122/checkpoint-therapeutics-announces-fda-acceptance-of-bla
https://www.fortressbiotech.com/investors/news-events/press-releases/detail/655/fortress-biotech-reduces-total-debt-and-enters-into-new-35
other-
https://ir.achievelifesciences.com/news-events/press-releases/detail/202/achieve-life-sciences-to-announce-second-quarter-financial
https://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-release-second-quarter-2024-financial-results
https://investors.x4pharma.com/node/11191/pdf

